US English UK English Polish Italian Hungarian Greek Spanish German Australian English


   
in the news

understanding
your tests

inside the lab

about this site

site map

send us your
comments


home
 


CF Gene Mutation Testing

Also known as: Cystic fibrosis (CF) genotyping, CF DNA analysis, CF gene mutation panel, Molecular genetic testing
Formal name: Cystic Fibrosis Gene Mutation Panel
Related tests: Sweat chloride, Immunoreactive trypsin (IRT), Stool trypsin
Common Questions
  1. Will this CF gene mutation test pick up any other genetic diseases?
2. What will my risk of being a carrier be if I am of mixed ethnicity?
3. What are the advantages of the DNA-based blood test over other CF screening tests?
4. Does the state require or offer newborn screening for CF? Do I need to request it?


1. Will this CF gene mutation test pick up any other genetic diseases? No, it is only checking for specific CF mutations. Every genetic disease requires specific DNA testing to identify it (assuming that the gene and mutations causing it are known).



2. What will my risk of being a carrier be if I am of mixed ethnicity? Generally, the frequency of CF carriers is highest in Caucasians (1/25), about half that in Hispanic Caucasians and African Americans, and about half that again in Asians. Some ethnic groups, such as individuals of Eastern European Jewish descent, may show CF confined to a very limited number of mutations (e.g., ?508) and elect for testing using a limited mutation panel. Since the ethnicity of the U.S. population is becoming increasingly blended, the historical data and statistical risks are changing. Your risk may be an unknown mix of your inherited ethnic risk. Some families may also carry the additional risk of specific rare mutations within their family line.



3. What are the advantages of the DNA-based blood test over other CF screening tests? Generally, the DNA-based mutation test is much more specific than other screening tests, which may yield abnormal results for non-CF reasons. Also, these other screening tests may be restricted as to when they can be applied (for example, newborns can not be tested with sweat chloride until about two months of age). Furthermore, DNA-based testing is the only reliable means of identifying carriers of CF mutations, and it is in this capacity that the testing is being most widely applied.



4. Does the state require or offer newborn screening for CF? Do I need to request it? More than a dozen states offer CF testing as part of their newborn screening tests, but screening requirements vary from state to state, as determined by individual state public health departments. Most states now have their own mandatory newborn screening program, but in some states, such as Wyoming and Maryland, the screening is not mandatory, so you may need to request it.






This article was last reviewed on January 23, 2006.
 
In the NewsUnderstanding Your TestsInside the Lab
About the SiteSite MapSend Us Your CommentsHome


We comply with the HONcode standard for trustworthy health
information:
verify here.


©2001-2008 American Association for Clinical Chemistry
Email concerns to

Terms of UsePrivacy